Frankfurt - Delayed Quote EUR
Viking Therapeutics, Inc. (1VT.F)
22.01
+0.18
+(0.85%)
As of 8:06:17 AM GMT+2. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 2.38M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| FOEHR MATTHEW W Director | Conversion of Exercise of derivative security at price 8.00 per share. | Direct | 166,288 | Apr 11, 2025 |
| ROUAN SARAH KATHRYN Director | Purchase at price 24.15 per share. | Direct | 29,943 | Mar 31, 2025 |
| ROUAN SARAH KATHRYN Director | Purchase at price 24.15 per share. | Direct | 29,943 | Mar 31, 2025 |
| ZANTE GREGORY S Chief Financial Officer | Sale at price 42.69 - 43.32 per share. | Direct | 2,150,595 | Jan 6, 2025 |
| LIAN BRIAN Chief Executive Officer | Sale at price 42.68 - 43.32 per share. | Direct | 8,313,601 | Jan 6, 2025 |
| MANCINI MARIANNA Chief Operating Officer | Sale at price 42.69 - 43.32 per share. | Direct | 2,317,599 | Jan 6, 2025 |
| ZANTE GREGORY S Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
| LIAN BRIAN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
| MANCINI MARIANNA Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 3, 2025 |
| MACARTNEY LAWSON Director | Sale at price 68.67 per share. | Direct | 137,333 | Nov 8, 2024 |
| MACARTNEY LAWSON Director | Conversion of Exercise of derivative security at price 5.80 per share. | Direct | 11,600 | Nov 8, 2024 |
| ZANTE GREGORY S Chief Financial Officer | Sale at price 74.56 - 81.44 per share. | Direct | 10,089,164 | Oct 28, 2024 |
| ZANTE GREGORY S Chief Financial Officer | Conversion of Exercise of derivative security at price 4.68 - 8.52 per share. | Direct | 704,282 | Oct 28, 2024 |
| SINGLETON J MATTHEW Director | Sale at price 79.50 per share. | Direct | 1,272,000 | Oct 25, 2024 |
| SINGLETON J MATTHEW Director | Conversion of Exercise of derivative security at price 4.48 per share. | Direct | 71,680 | Oct 25, 2024 |
| ROUAN SARAH KATHRYN Director | Sale at price 80.89 per share. | Direct | 889,790 | Oct 25, 2024 |
| ROUAN SARAH KATHRYN Director | Conversion of Exercise of derivative security at price 4.88 per share. | Direct | 53,680 | Oct 25, 2024 |
| SINGLETON J MATTHEW Director | Sale at price 69.50 per share. | Direct | 715,850 | Sep 20, 2024 |
| SINGLETON J MATTHEW Director | Conversion of Exercise of derivative security at price 1.19 per share. | Direct | 12,257 | Sep 20, 2024 |
| LIAN BRIAN Chief Executive Officer | Sale at price 70.43 - 71.98 per share. | Direct | 15,308,553 | Sep 20, 2024 |
| LIAN BRIAN Chief Executive Officer | Conversion of Exercise of derivative security at price 7.77 per share. | Direct | 1,290,830 | Sep 20, 2024 |
| SINGLETON J MATTHEW Director | Sale at price 69.72 per share. | Direct | 397,430 | Aug 21, 2024 |
| SINGLETON J MATTHEW Director | Conversion of Exercise of derivative security at price 1.19 per share. | Direct | 6,783 | Aug 21, 2024 |
| LIAN BRIAN Chief Executive Officer | Sale at price 69.90 per share. | Direct | 69,900 | Aug 21, 2024 |
| LIAN BRIAN Chief Executive Officer | Conversion of Exercise of derivative security at price 7.77 per share. | Direct | 7,770 | Aug 21, 2024 |
| SINGLETON J MATTHEW Director | Sale at price 60.01 - 64.88 per share. | Direct | 995,453 | Aug 19, 2024 |
| SINGLETON J MATTHEW Director | Conversion of Exercise of derivative security at price 3.33 per share. | Direct | 53,280 | Aug 19, 2024 |
| LIAN BRIAN Chief Executive Officer | Sale at price 65.33 - 67.12 per share. | Direct | 7,426,508 | Aug 19, 2024 |
| LIAN BRIAN Chief Executive Officer | Conversion of Exercise of derivative security at price 7.77 per share. | Direct | 877,000 | Aug 19, 2024 |
| SINGLETON J MATTHEW Director | Sale at price 57.52 - 58.37 per share. | Direct | 1,195,736 | Aug 14, 2024 |
| SINGLETON J MATTHEW Director | Conversion of Exercise of derivative security at price 8.00 per share. | Direct | 166,288 | Aug 14, 2024 |
| ZANTE GREGORY S Chief Financial Officer | Sale at price 56.96 - 58.71 per share. | Direct | 922,212 | Jul 30, 2024 |
| LIAN BRIAN Chief Executive Officer | Sale at price 56.95 - 58.78 per share. | Direct | 6,670,604 | Jul 30, 2024 |
| MANCINI MARIANNA Chief Operating Officer | Sale at price 56.98 - 57.82 per share. | Direct | 1,029,912 | Jul 30, 2024 |
| ZANTE GREGORY S Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 29, 2024 |
| LIAN BRIAN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 29, 2024 |
| MANCINI MARIANNA Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 29, 2024 |
| ZANTE GREGORY S Chief Financial Officer | Sale at price 73.49 - 76.07 per share. | Direct | 4,986,008 | May 3, 2024 |
| ZANTE GREGORY S Chief Financial Officer | Conversion of Exercise of derivative security at price 4.68 - 4.88 per share. | Direct | 166,285 | May 3, 2024 |
| MANCINI MARIANNA Chief Operating Officer | Sale at price 76.40 - 80.08 per share. | Direct | 22,136,474 | May 1, 2024 |
| MANCINI MARIANNA Chief Operating Officer | Conversion of Exercise of derivative security at price 4.68 - 8.52 per share. | Direct | 1,740,575 | May 1, 2024 |
| ZANTE GREGORY S Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 27, 2024 |
| LIAN BRIAN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 27, 2024 |
| MANCINI MARIANNA Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 27, 2024 |
| ZANTE GREGORY S Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| LIAN BRIAN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| MANCINI MARIANNA Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| LIAN BRIAN Chief Executive Officer | Sale at price 29.90 per share. | Direct | 1,345,500 | Feb 9, 2024 |
| LIAN BRIAN Chief Executive Officer | Sale at price 25.75 - 28.90 per share. | Direct | 7,230,784 | Feb 8, 2024 |
| LIAN BRIAN Chief Executive Officer | Conversion of Exercise of derivative security at price 1.23 - 4.65 per share. | Direct | 711,367 | Feb 8, 2024 |
Related Tickers
PI3.DU Gubra AS
46.92
-2.70%
LYTIX.OL Lytix Biopharma AS
5.26
-2.23%
ASMB Assembly Biosciences, Inc.
10.41
+3.38%
SPRB Spruce Biosciences, Inc.
0.1329
+2.55%
PTCT PTC Therapeutics, Inc.
49.95
+3.65%
LCTX Lineage Cell Therapeutics, Inc.
0.4720
+9.82%
VNDA Vanda Pharmaceuticals Inc.
4.3300
-1.81%
GRCE Grace Therapeutics, Inc.
2.3000
+0.44%
CANF Can-Fite BioPharma Ltd.
1.1800
+0.85%
TSHA Taysha Gene Therapies, Inc.
1.8200
+2.25%